North America Bioreactors Market Size By Technology (Wave-induced Motion SUB, Stirred SUB, Single Use Bubble Column), By Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy), By End-use (R&D Organizations, Biopharma Manufacturers, CMOs), By Cell (Mammalian Cells, Bacterial Cells, Yeast Cells), Industry Analysis Report, Country Outlook (U.S., Canada), Application Potential, Competitive Market Share & Forecast, 2019 - 2025

Published Date: July 2019 | Publisher: Graphical Research Report ID: GR1222 | Delivery : PDF

Report Content

Chapter 1.   Methodology

1.1.   Definition and forecast parameters

1.1.1.  Definitions

1.1.2.  Methodology and forecast parameters        

1.2.   Data sources 

1.3.   References & sources

1.3.1.  Secondary

1.3.2.  Primary

Chapter 2.  Executive Summary

2.1.   North America bioreactors industry summary, 2014 – 2025

2.1.1.  Country trends

2.1.2.  Cell trends

2.1.3.  Molecule trends

2.1.4.  Technology trends

2.1.5.  End-use trends

Chapter 3.  Industry Insights

3.1.   Industry segmentation

3.2.   Industry outlook, 2014 - 2025

3.3.   Major factor analysis

3.3.1.  Drivers

3.3.1.1.   Growing biopharmaceuticals and biologics industry

3.3.1.2.   Technological advancements in bioreactors

3.3.1.3.   Growing orphan drugs developments

3.3.1.4.   Increasing demand for personalized medicines

3.3.2.  Restraints & challenges

3.3.2.1.   Low capacity of single-use bioreactor

3.3.2.2.   Concerns regarding extractables and/or leachable

3.4.   Regulatory landscape

3.4.1.  U.S.

3.4.2.  Canada

3.5.   Technology landscape

3.6.   Porter’s analysis

3.7.   Competitive review, 2017

3.8.   PEST analysis

Chapter 4.   North America Bioreactors Market, By Cell

4.1.   Key trends in North America bioreactors, by cell

4.2.   Mammalian cells

4.2.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

4.3.   Bacterial cells

4.3.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

4.4.   Yeast cells

4.4.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

4.5.   Others

4.5.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

Chapter 5.   North America Bioreactors Market, By Molecule

5.1.   Key trends in North America bioreactors, by molecule

5.2.   Monoclonal antibodies

5.2.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

5.3.   Vaccines

5.3.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

5.4.   Recombinant protein

5.4.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

5.5.   Stem cell

5.5.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

5.6.   Gene therapy

5.6.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

5.7.   Others

5.7.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

Chapter 6.  North America Bioreactors Market, By Technology

6.1.   Key trends in North America bioreactors, by technology

6.2.   Wave-induced motion SUB

6.2.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

6.3.   Stirred SUB

6.3.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

6.4.   Stirred-use bubble column

6.4.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

6.5.   Others

6.5.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

Chapter 7.   North America Bioreactors Market, By End-use

7.1.   Key trends in North America bioreactors, by end-use

7.2.   Research and development (R&D) organizations

7.2.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

7.3.   Biopharma manufacturers

7.3.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

7.4.   Contract manufacturing organizations (CMOs)

7.4.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

Chapter 8.  North America Bioreactors Market, By Country

8.1.   Key trends in North America bioreactors, by country

8.2.   U.S.

8.2.1.   Market estimates and forecast, 2014 – 2025 (USD Million)

8.2.2.   Market estimates and forecast, by cell, 2014 – 2025 (USD Million)

8.2.3.   Market estimates and forecast, by molecule, 2014 – 2025 (USD Million)

8.2.4.   Market estimates and forecast, by technology, 2014 – 2025 (USD Million)

8.2.5.   Market estimates and forecast, by end-use, 2014 – 2025 (USD Million)

8.3.   Canada

8.3.1.   Market estimates and forecast, 2014 – 2025 (USD Million)

8.3.2.   Market estimates and forecast, by cell, 2014 – 2025 (USD Million)

8.3.3.   Market estimates and forecast, by molecule, 2014 – 2025 (USD Million)

8.3.4.   Market estimates and forecast, by technology, 2014 – 2025 (USD Million)

8.3.5.   Market estimates and forecast, by end-use, 2014 – 2025 (USD Million)

Chapter 9.  Company Profiles

9.1.   Thermo Fisher Scientific

9.1.1.  Business overview

9.1.2.  Financial data

9.1.3.  Product landscape

9.1.4.  Strategic outlook

9.1.5.  SWOT analysis

9.2.   PBS Biotech

9.2.1.  Business overview

9.2.2.  Financial data

9.2.3.  Product landscape

9.2.4.  Strategic outlook

9.2.5.  SWOT analysis

9.3.   GE Healthcare

9.3.1.  Business overview

9.3.2.  Financial data

9.3.3.  Product landscape

9.3.4.  Strategic outlook

9.3.5.  SWOT analysis

9.4.   Merck Group

9.4.1.  Business overview

9.4.2.  Financial data

9.4.3.  Product landscape

9.4.4.  Strategic outlook

9.4.5.  SWOT analysis

9.5.   Cellexus Ltd

9.5.1.  Business overview

9.5.2.  Financial data

9.5.3.  Product landscape

9.5.4.  Strategic outlook

9.5.5.  SWOT analysis

9.6.   Pall Corporation

9.6.1.  Business overview

9.6.2.  Financial data

9.6.3.  Product landscape

9.6.4.  Strategic outlook

9.6.5.  SWOT analysis

9.7.   Sartorius Stedim Biotech Group

9.7.1.  Business overview

9.7.2.  Financial data

9.7.3.  Product landscape

9.7.4.  Strategic outlook

9.7.5.  SWOT analysis

9.8.   Applikon Biotechnology, Inc.

9.8.1.   Business overview

9.8.2.   Financial data

9.8.3.   Product landscape

9.8.4.   Strategic outlook

9.8.5.   SWOT analysis

9.9.   GEA Group Aktiengesellschaft

9.9.1.   Business overview

9.9.2.   Financial data

9.9.3.   Product landscape

9.9.4.   Strategic outlook

9.9.5.   SWOT analysis

9.10. BioTron, Inc.

9.10.1. Business overview

9.10.2. Financial data

9.10.3. Product landscape

9.10.4. Strategic outlook

9.10.5. SWOT analysis

9.11. Eppendorf AG

9.11.1. Business overview

9.11.2. Financial data

9.11.3. Product landscape

9.11.4. Strategic outlook

9.11.5. SWOT analysis

9.12. Solaris Biotech Solutions

9.12.1. Business overview

9.12.2. Financial data

9.12.3. Product landscape

9.12.4. Strategic outlook

9.12.5. SWOT analysis

 

Data Tables

TABLE 1.          North America market estimates by country, (USD Mn), 2014 - 2018

TABLE 2.          North America market forecast by country, (USD Mn), 2019 - 2025

TABLE 3.          North America market estimates by cell, (USD Mn), 2014 - 2018

TABLE 4.          North America market forecast by cell, (USD Mn), 2019 - 2025

TABLE 5.          North America market estimates by molecule, (USD Mn), 2014 - 2018

TABLE 6.          North America market forecast by molecule, (USD Mn), 2019 - 2025

TABLE 7.          North America market estimates by technology, (USD Mn), 2014 - 2018

TABLE 8.          North America market forecast by technology, (USD Mn), 2019 - 2025

TABLE 9.          North America market estimates by end-use, (USD Mn), 2014 - 2018

TABLE 10.        North America market forecast by end-use, (USD Mn), 2019 - 2025

TABLE 11.        Competition review

TABLE 12.        North America mammalian cells market estimates, (USD Mn), 2014 - 2018

TABLE 13.        North America mammalian cells market forecast, (USD Mn), 2019 - 2025

TABLE 14.        North America bacterial cells market estimates, (USD Mn), 2014 - 2018

TABLE 15.        North America bacterial cells market forecast, (USD Mn), 2019 - 2025

TABLE 16.        North America yeast cells market estimates, (USD Mn), 2014 – 2018

TABLE 17.        North America yeast cells market forecast, (USD Mn), 2019 - 2025

TABLE 18.        North America others market estimates, (USD Mn), 2014 – 2018

TABLE 19.        North America others market forecast, (USD Mn), 2019 - 2025

TABLE 20.        North America monoclonal antibodies market estimates, (USD Mn), 2014 - 2018

TABLE 21.        North America monoclonal antibodies market forecast, (USD Mn), 2019 – 2025

TABLE 22.        North America vaccines market estimates, (USD Mn), 2014 - 2018

TABLE 23.        North America vaccines market forecast, (USD Mn), 2019 - 2025

TABLE 24.        North America recombinant protein market estimates, (USD Mn), 2014 - 2018

TABLE 25.        North America recombinant protein market forecast, (USD Mn), 2019 - 2025

TABLE 26.        North America stem cell market estimates, (USD Mn), 2014 - 2018

TABLE 27.        North America stem cell market forecast, (USD Mn), 2019 - 2025

TABLE 28.        North America gene therapy market estimates, (USD Mn), 2014 - 2018

TABLE 29.        North America gene therapy market forecast, (USD Mn), 2019 - 2025

TABLE 30.        North America others market estimates, (USD Mn), 2014 - 2018

TABLE 31.        North America others market forecast, (USD Mn), 2019 - 2025

TABLE 32.        North America wave-induced motion SUB market estimates, (USD Mn), 2014 - 2018

TABLE 33.        North America wave-induced motion SUB market forecast, (USD Mn), 2019 – 2025

TABLE 34.        North America stirred SUB market estimates, (USD Mn), 2014 – 2018

TABLE 35.        North America stirred SUB market forecast, (USD Mn), 2019 – 2025

TABLE 36.        North America stirred-use bubble column market estimates, (USD Mn), 2014 - 2018

TABLE 37.        North America stirred-use bubble column market forecast, (USD Mn), 2019 - 2025

TABLE 38.        North America others monitors market estimates, (USD Mn), 2014 - 2018

TABLE 39.        North America others monitors market forecast, (USD Mn), 2019 - 2025

TABLE 40.        North America research and development (R&D) organizations market estimates, (USD Mn), 2014 - 2018

TABLE 41.        North America research and development (R&D) organizations market forecast, (USD Mn), 2019 - 2025

TABLE 42.        North America biopharma manufacturers market estimates, (USD Mn), 2014 - 2018

TABLE 43.        North America biopharma manufacturers market forecast, (USD Mn), 2019 - 2025

TABLE 44.        North America contract manufacturing organizations (CMOs) market estimates, (USD Mn), 2014 - 2018

TABLE 45.        North America contract manufacturing organizations (CMOs) market forecast, (USD Mn), 2019 - 2025

TABLE 46.        U.S. bioreactors market estimates, (USD Mn), 2014 - 2018

TABLE 47.        U.S. bioreactors market forecast, (USD Mn), 2019 - 2025

TABLE 48.        U.S. market size by cell, (USD Million), 2014 - 2018

TABLE 49.        U.S. market size by cell, (USD Million), 2019 – 2025

TABLE 50.        U.S. market size by molecule, (USD Million), 2014 - 2018

TABLE 51.        U.S. market size by molecule, (USD Million), 2019 – 2025

TABLE 52.        U.S. market size by technology, (USD Million), 2014 - 2018

TABLE 53.        U.S. market size by technology, (USD Million), 2019 – 2025

TABLE 54.        U.S. market size by end-use, (USD Million), 2014 - 2018

TABLE 55.        U.S. market size by end-use, (USD Million), 2019 – 2025

TABLE 56.        Canada bioreactors market estimates, (USD Mn), 2014 - 2018

TABLE 57.        Canada bioreactors market forecast, (USD Mn), 2019 - 2025

TABLE 58.        Canada market size by cell, (USD Million), 2014 - 2018

TABLE 59.        Canada market size by cell, (USD Million), 2019 – 2025

TABLE 60.        Canada market size by molecule, (USD Million) 2014 - 2018

TABLE 61.        Canada market size by molecule, (USD Million), 2019 – 2025

TABLE 62.        Canada market size by technology, (USD Million), 2014 - 2018

TABLE 63.        Canada market size by technology, (USD Million), 2019 – 2025

TABLE 64.        Canada market size by end-use, (USD Million), 2014 - 2018

TABLE 65.        Canada market size by end-use, (USD Million), 2019 – 2025

Charts & Figures

FIG 1.     Industry segmentation

FIG 2.     North America bioreactors industry outlook, 2014 - 2025

FIG 3.     Porter’s analysis

FIG 4.     PEST analysis

Select License

North America Bioreactors Market Share | Analysis Report 2019-2025


Related Reports
Why Choose us?